Volasertib

ID: ALA4284151

Max Phase: Preclinical

Molecular Formula: C34H50N8O3

Molecular Weight: 618.83

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCC(N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C

Standard InChI:  InChI=1S/C34H50N8O3/c1-6-28-33(44)39(4)29-20-35-34(38-31(29)42(28)22(2)3)37-27-14-9-24(19-30(27)45-5)32(43)36-25-10-12-26(13-11-25)41-17-15-40(16-18-41)21-23-7-8-23/h9,14,19-20,22-23,25-26,28H,6-8,10-13,15-18,21H2,1-5H3,(H,36,43)(H,35,37,38)/t25?,26?,28-/m1/s1

Standard InChI Key:  SXNJFOWDRLKDSF-XKHVUIRMSA-N

Molfile:  

     RDKit          2D

 45 50  0  0  0  0  0  0  0  0999 V2000
   15.1841   -5.1343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1841   -5.9515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8894   -6.3559    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.8894   -4.7215    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.8894   -7.1731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1816   -7.5817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5971   -7.5817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8894   -3.9044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4752   -4.7278    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.4770   -6.3611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7687   -5.9535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5946   -5.1343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5930   -5.9497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2973   -6.3569    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0035   -5.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0012   -5.1315    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2964   -4.7279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7117   -6.3579    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.4190   -5.9486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1254   -6.3591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8322   -5.9504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8318   -5.1324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1187   -4.7247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4148   -5.1356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1245   -7.1763    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.8317   -7.5856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5386   -4.7221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2472   -5.1291    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5367   -3.9049    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.9540   -4.7188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6598   -5.1295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3645   -4.7228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3668   -3.9052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6583   -3.4961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9474   -3.9045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0751   -3.4977    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.7790   -3.9105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4852   -3.5064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4906   -2.6888    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.7837   -2.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0713   -2.6828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2005   -2.2839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9060   -2.6962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3110   -3.4037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7233   -2.6981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3 13  1  0
 12  4  1  0
  3  5  1  0
  5  6  1  0
  5  7  1  0
  4  8  1  0
  1  9  2  0
  2 10  1  6
 10 11  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 15 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 20 25  1  0
 25 26  1  0
 22 27  1  0
 27 28  1  0
 27 29  2  0
 28 30  1  0
 30 31  1  0
 30 35  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 33 36  1  0
 36 37  1  0
 36 41  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 39 42  1  0
 42 43  1  0
 44 43  1  0
 45 44  1  0
 43 45  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4284151

    ---

Associated Targets(Human)

ZR-75-1 (953 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-474 (2113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-BR-3 (5175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-468 (9477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 618.83Molecular Weight (Monoisotopic): 618.4006AlogP: 4.27#Rotatable Bonds: 10
Polar Surface Area: 106.17Molecular Species: BASEHBA: 9HBD: 2
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.25CX Basic pKa: 8.70CX LogP: 4.20CX LogD: 2.89
Aromatic Rings: 2Heavy Atoms: 45QED Weighted: 0.40Np Likeness Score: -1.26

References

1. Pan Z, Chen Y, Liu J, Jiang Q, Yang S, Guo L, He G..  (2018)  Design, synthesis, and biological evaluation of polo-like kinase 1/eukaryotic elongation factor 2 kinase (PLK1/EEF2K) dual inhibitors for regulating breast cancer cells apoptosis and autophagy.,  144  [PMID:29288948] [10.1016/j.ejmech.2017.12.046]

Source